Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07419360 · ClinicalTrials.gov registry record · NA
DRAIN: DRainage in Acute Decompensated Heart faIlure With Pleural effusioNs
A NA study of Congestive Heart Failure(CHF) and Pleural Effusion Due to Congestive Heart Failure, sponsored by Albany Medical College.
- Recruiting
- Registry status
- NA
- Development phase
- 216
- Enrollment target
- 1
- Study location
NCT07419360: Recruiting NA study of Congestive Heart Failure(CHF) and Pleural Effusion Due to Congestive Heart Failure, sponsored by Albany Medical College.
NCT07419360 is a NA study of Congestive Heart Failure(CHF) and Pleural Effusion Due to Congestive Heart Failure that is actively recruiting participants, run by Albany Medical College. The registered enrollment target is 216 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07419360, a NA study of Congestive Heart Failure(CHF) and Pleural Effusion Due to Congestive Heart Failure, is actively recruiting participants, sponsored by Albany Medical College.
- RECRUITING
- Registry status
- NA
- Development phase
- 216 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to assess if removal of fluid around the lungs (pleural effusion) by a routine procedure called as thoracentesis is helpful to decrease shortness of breath in hospitalized patients with congestive heart failure and have pleural effusion. Researchers will compare thoracentesis with medical therapy to medical therapy alone to see if one treatment is superior to the other treatment in relieving shortness of breath. Participants will : 1. Receive medical therapy with or without thoracentesis 2. Record degree of shortness of breath and quality of life before and after the intervention using predefined standard scales. 3. Telephonic call for 15- 30 mins at day 14 and 30 after enrollment to assess shortness of breath and quality of life
Primary Outcome
Degree of dyspnea will be assessed as by using a validated 100 mm visual analog scale in participants of both groups. Dyspnea will be assessed using a 100 mm visual analog scale (VAS). The VAS consisted of a horizontal straight line with endpoints defining extreme limits, with the left end marked as "no trouble" (0 mm) and the right end as "very much trouble" (100 mm). A higher VAS score indicated more severe dyspnea. The minimal clinically important difference (MCID) was defined as ≥ 14 mm impr
Conditions Studied
Interventions
- PROCEDURE Thoracentesis
Study Locations (1)
New York
- Albany Medical Center - Albany
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 216 participants |
| Start Date | 2026-02-15 |
| Est. Completion | 2030-03 |
| Phase | NA |
What NCT07419360 shows while recruiting
NCT07419360 is an interventional study that assigns participants to a tested intervention. The registered 216 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 2 conditions, with Congestive Heart Failure(CHF) appearing as the primary indexed condition, and to 1 intervention - of which Thoracentesis is the first listed.
NCT07419360 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07419360 about?
NCT07419360 is a clinical study titled "DRAIN: DRainage in Acute Decompensated Heart faIlure With Pleural effusioNs". The goal of this study is to assess if removal of fluid around the lungs (pleural effusion) by a routine procedure called as thoracentesis is helpful to decrease shortness of breath in hospitalized patients with congestive heart failure and have pleural effusion. Researchers will compare thoracente...
What is the current status of trial NCT07419360?
This trial is currently recruiting. It is a NA study. The enrollment target is 216 participants. The study started on 2026-02-15. Estimated completion is 2030-03.
What conditions does trial NCT07419360 study?
This clinical trial studies the following conditions: Congestive Heart Failure(CHF), Pleural Effusion Due to Congestive Heart Failure.
What interventions are being tested in trial NCT07419360?
The interventions under investigation include: Thoracentesis (PROCEDURE).
Who is sponsoring clinical trial NCT07419360?
This trial is sponsored by Albany Medical College, which has 52 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07419360 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congestive Heart Failure(CHF)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07419360's enrollment target sits among peer trials
216 485th of 2000 higher than 1,514 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02609685 · 216 participants · NA
Active Surveillance of Papillary Thyroid Microcarcinoma
- NCT04994873 · 216 participants · NA
Skills to Enhance Positivity in Suicidal Youth
- NCT05264779 · 216 participants · NA
The Periviable GOALS Decision Support Tool
- NCT05434130 · 216 participants · Phase 2
Modulating Exercise Dosage to Improve Concussion Recovery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI